ArticleJournal of medical ethics2007
The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer.
Article in Journal of medical ethics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 35 citations in OpenAlex.
- Advance care planning and end-of-life care in patients with an implantable cardioverter defibrillator: The perspective of relatives.Palliative medicine · 2021Article
- Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.Heart (British Cardiac Society) · 2020Article
- The Evolving Moral Landscape Of Palliative Care.Health affairs (Project Hope) · 2018Article
- [Ethics in intensive care and euthanasia : With respect to inactivating defibrillators at the end of life in terminally ill patients].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2017Review
- [Dying with/despite a pacemaker].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2014Article
- Prolegomena to any future mereology of the body.Theoretical medicine and bioethics · 2013Article
- [The chronic critically ill patient from the cardiologist's perspective].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2013Review
- A review of ethical considerations for ventricular assist device placement in older adults.Aging and disease · 2013Article
- The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.Deutsches Arzteblatt international · 2012Review
- Ethical Dilemmas and End-of-Life Choices for Patients with Implantable Cardiac Devices: Decisions Regarding Discontinuation of Therapy.Current treatment options in cardiovascular medicine · 2011Article
- The ethics of implantable devices.Journal of medical ethics · 2007Article
- Ethical dilemmas surrounding the use of ventricular assist devices in supporting patients with end-stage organ dysfunction.Methodist DeBakey cardiovascular journalReview
Corrections and comments
- Commented on by
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this paper, the ethical and legal issues raised by the deactivation of implantable cardioverter-defibrillators (ICDs) in patients with terminal cancer is considered. It is argued that the ICD cannot be well described either as a treatment or as a non-treatment option, and thus raises complex questions regarding how rules governing deactivation should be framed. A new category called "integral devices" is proposed. Integral devices require their own special rules, reflecting their position as a "halfway house" between a form of treatment and a part of the body. The practical problems faced by doctors working in palliative medicine with regard to the deactivation of ICDs are also considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.